AVeta Medical is femtech medical device company that aims to revolutionise the treatment of vaginal atrophy.
VITA AV is a hormone-free, safe, targeted therapy to treat vaginal symptoms of genitourinary syndrome of menopause (GSM), also known as vaginal atrophy (VA). Treatment is immediate, provides long-lasting symptom relief. As the treatment is based on the body’s natural healing response, it presents with no side effects. Aveta Medical has completed a First in Human Trial with the VITA AV Clinical System which provided positive indications with 8 out of 12 participants reporting the reduction or elimination of symptoms. There were no adverse events or pain during treatment recorded during the trial. The technology has been patented. Approval process for FDA and EU MDR for commercial use is ongoing.
